Patterson Belknap
Microsoft has discontinued support for Internet Explorer. To access the Patterson Belknap website, please install a modern browser like Microsoft Edge or Google Chrome.
We use cookies to enhance your experience of our website and provide us with information on how you use our website. For more information about the way our site uses cookies, please read our Privacy Policy. Click "Accept Cookies" to enable cookies and third-party content or “Decline” to decline the use of cookies.
Accept CookiesDecline
mobile logo
High Contrast Mode
  • Search
  • People
  • Practices
  • Values
    Inclusion and Engagement
    Pro Bono
    Core Values
  • Firm
    About Our Firm
    Careers : Attorneys
    Careers: Business Services
    Contact Us
    Blogs & Podcasts
    Firm News
    Publications
    Events
Skip Nav
Patterson Belknap Logo
Inclusion and Engagement
Pro Bono
Core Values
About Our Firm
Careers
AttorneysBusiness Services
Contact Us
News & Resources
Blogs & PodcastsFirm NewsPublicationsEvents

Find a Person


Search
  • A
    B
    C
    D
    E
    F
    G
    H
    I
    J
    K
    L
    M
  • N
    O
    P
    Q
    R
    S
    T
    U
    V
    W
    X
    Y
    Z
  • View All
  • A
    B
    C
    D
    E
    F
    G
    H
    I
    J
    K
    L
    M
    N
    O
    P
    Q
    R
    S
    T
    U
    V
    W
    X
    Y
    Z
    View All

Find a Practice

Search
  • Corporate & Transactions
  • Exempt Organizations & Private Clients
  • Litigation, Disputes & Investigations
  • All Practices
printable-logo

Firm News

Search

October 19, 2020

Firm Represents Leviton Manufacturing Co., Inc. in its Acquisition of Leading Fiber-Optic and Copper Network Cabling Manufacturer

October 19, 2020

Firm Represents Zero Motorcycles in Strategic Alliance Related to EV

October 15, 2020

Firm Achieves Top Rankings in Benchmark Litigation 2021 Guide

October 5, 2020

Firm Secures Victory in Counterfeit Suit for Medical Device Manufacturer

October 5, 2020

Partner Jane Metcalf Named to Ad Age's "40 Under 40" List

September 23, 2020

Firm Secures Dismissal With Prejudice in Patent Litigation Against Sony Electronics

September 16, 2020

Firm Receives Top Marks in Vault’s 2021 Associate Survey

September 16, 2020

Firm Secures Dismissal of Putative Consumer False Advertising Class Action in SDNY

August 28, 2020

Firm Secures Watershed Chancery Ruling in Student Loan Trust Case

August 18, 2020

Firm Secures Significant Victory for Major Medical Device Manufacturer in False Advertising Suit

July 30, 2020

Four Patterson Belknap Partners Named to Benchmark Litigation’s 2020 “40 & Under Hot List”

July 24, 2020

Firm Files Lawsuit Challenging Decision to Exclude Undocumented Immigrants in Counts for Dividing Up Congress’ Seats

July 21, 2020

Patterson Belknap Recognized by Chambers High Net Worth 2020 for Art and Cultural Property Law Practice

July 15, 2020

Firm Submits Comments on Proposed Federal Regulations on Behalf of the National Citizen and Immigration Services Council 119

July 8, 2020

Firm Secures Victory for Former President of Global Fuel Company

June 25, 2020

Firm Secures Seizure Order for Dangerous Counterfeit Medical Devices

June 24, 2020

Firm Files Amicus Brief on Behalf of an Interfaith Coalition in Supreme Court DACA Case

June 23, 2020

Firm Earns Continued Top-Tier Practice Rankings From The Legal 500 United States

June 17, 2020

Firm Secures First Circuit Victory for The Hershey Company in Class Action Lawsuit

June 17, 2020

Firm’s Amicus Briefs “On the Right Side of History” in Landmark LGBTQ Supreme Court Decision

June 4, 2020

Firm Successfully Opposes Entry of Unauthorized Consent Judgment in Student Loan Trusts Enforcement Action

May 28, 2020

Firm Files Amicus Brief on Behalf of Law Professors in Second Circuit Immigration Case

May 12, 2020

Firm Secures Case-Ending Sanctions Victory for Multinational Healthcare Company

May 11, 2020

Patterson Belknap Launches State Attorneys General Practice

April 24, 2020

Firm Secures Trial Win for Surgical Device Manufacturer

April 23, 2020

13 Patterson Belknap Attorneys and Six Practices Receive Recognition in Chambers USA 2020

April 20, 2020

Firm Secures Second Circuit Affirmance on Behalf of Hedge Fund in Breach of Contract Case

March 31, 2020

Firm Partners with City Bar Justice Center to Provide Free Life-Planning Legal Assistance to COVID-19 Front-Line Health Care Workers in NYC

March 27, 2020

Firm Secures Case-Ending Win for Medical Device Manufacturer in Anti-Diversion Trademark Case

March 3, 2020

Firm Secures Federal Circuit Affirmance in Patent Trial

March 2, 2020

Daniel Ruzumna Named Among NLJ's 2020 "Criminal Law Trailblazers"

February 26, 2020

Firm Secures Unprecedented Settlement on Behalf of Deceased Inmate

February 10, 2020

Patterson Belknap Names 2020 LCLD Pathfinder

February 7, 2020

Firm Secures Duty-Free Treatment for HIV Drug

January 21, 2020

Firm Recognized Among 2020 “Best Places to Work” for LGBTQ Equality

January 17, 2020

Firm Files Amicus Brief in Neiman Marcus Bondholders’ Fraudulent Conveyance Case

January 6, 2020

Patterson Belknap Publishes an Updated, Second Edition of the New York Commercial Division Practice Guide

December 17, 2019

Firm Secures Temporary Restraining Order for Technology Company in Anti-Counterfeiting Lawsuit

December 17, 2019

Lisa E. Cleary Named Among Crain’s New York Business’ 2020 Notable Women in Law

December 10, 2019

Patterson Belknap Announces Two New Partners and Five Counsel

December 3, 2019

Firm Secures Tenth Circuit Affirmance in Patent Licensing Dispute

November 25, 2019

Firm Secures Federal Circuit Affirmance for Medical Device Manufacturer in Glucose Test Strip Patent Litigation

November 18, 2019

Firm Secures Seventh Circuit Affirmance for Global Pharmaceutical Company in “Off-Label” RICO Suit

October 29, 2019

Firm Attorneys Honored by Legal Services Organizations

October 16, 2019

Jonah Knobler Named as a 2019 NYLJ Rising Star

October 10, 2019

Firm Obtains Victory for Tax-Exempt Clients in Suit Over First Amendment Rights

October 7, 2019

Firm Represents Pharmaceutical Company’s Board of Directors in Dismissal of Shareholder Derivative Lawsuit

October 1, 2019

Firm Achieves Top Rankings in Benchmark Litigation 2020 Guide

Page 5 of 13

Subscribe

Sign up

Firm Highlights

Publication
The Growing Antitrust Risks Of AI Pricing For Health Insurers
As algorithmic pricing models continue to gain traction throughout industries, they increasingly face scrutiny from legislators, enforcers and private plaintiffs who fear their anticompetitive potential. The health insurance industry is no exception: Courts are seriously considering challenges to algorithmic models for health insurance pricing, and legislators are also stepping in. This article focuses on recent legislative and enforcement trends to regulate this developing technology, as well as two ongoing cases involving algorithmic pricing in the health insurance industry, In re: MultiPlan Health Insurance Provider Litigation in the U.S. District Court for the Northern District of Illinois and In re: Zelis Repricing Antitrust Litigation in the U.S. District Court for the District of Massachusetts. Both cases are now in discovery as the plaintiffs continue to pursue...
Firm News
Patterson Belknap Recognized by Chambers in its 2026 High Net Worth Guide
Patterson Belknap Webb & Tyler is pleased to announce that the firm has been recognized by Chambers High Net Worth 2026 in the following practice areas: Art and Cultural Property Law – USA-Nationwide Private Wealth Law – New York Chambers is a leading independent professional legal research company, delivering detailed rankings and insights into the world’s top lawyers and law firms. Its research methodology includes detailed interviews with clients and peers and analysis of capabilities, achievement, and sector presence. The firm also received individual recognitions by Chambers in both practice areas: Anne-Laure Alléhaut is ranked in the Art and Cultural Property Law practice area in the USA. Michael Arlein is ranked in the Private Wealth Law practice area in New York. Comments regarding the firm in the Chambers High Net Worth...
Blog Post
Supreme Court Reaffirms Disgorgement in Sripetch, But Jury Question Looms
In our January 2026 post, Supreme Court to Clarify the SEC’s Disgorgement Powers, we previewed the Supreme Court’s decision to take up Sripetch v. Securities & Exchange Commission,[1] a case in which defendants sought to pare back the SEC’s authority to seek disgorgement. The case resolves a circuit split that arose in the wake of Liu v. SEC.[2]  In Liu, the Court sought to clarify the SEC’s ability to impose the penalty of disgorgement, ruling that disgorgement was available as equitable relief, but to avoid transforming an equitable remedy into a punitive one, “the remedy [is restricted] to an individual wrongdoer’s net profits to be awarded for victims.” In response to Liu’s requirement that disgorgement be “awarded for victims,” the Second Circuit...
Blog Post
Regulation E-Delivery: SEC Proposes to Make Electronic Communication the Default
On July 16, 2026, the Securities and Exchange Commission announced a proposed rule to broaden many financial market participants’ use of electronic communications with investors and others who receive information pursuant to federal securities laws.[1]  Referred to as “Reg E-Delivery,” the new rule aims to help issuers and others who disseminate SEC-required information transition away from delivering paper documents, a communication method the Agency pointed out imposes “unnecessary costs and expenses” while “no longer reflect[ing] the preference of most investors.”[2] Commenting on the proposed rule, Chair Atkins stated: The world has changed dramatically since many of our rules were first adopted. But, all too often, our regulatory framework has remained static. … In an age of artificial intelligence and blockchain technology, a...
Firm News
Firm Tops The American Lawyer's 2026 Pro Bono Scorecard with Number 1 Ranking
Patterson Belknap has been recognized with a number 1 ranking in The American Lawyer's 2026 Pro Bono Scorecard. These rankings assess pro bono efforts among Am Law 200 firms and are based on the average number of pro bono hours per lawyer and the percentage of lawyers performing 20 or more pro bono hours in 2025. The Scorecard highlights the firm's “intense focus” on pro bono work, with an average of 185.7 hours per lawyer and 85.1% of firm lawyers doing more than 20 hours of pro bono. The article includes commentary from Pro Bono Chair, Michael F. Buchanan, on the firm’s commitment to both impact litigation and pro bono work that has an impact on people's lives, such as access to health care,...
Publication
Not Over Yet?: Drug Manufacturers Eye Potential Circuit Split on Federal Drug Pricing Program
The Inflation Reduction Act’s Drug Price Negotiation Program has been the subject of litigation since Congress passed it in 2022 in an effort to curb the cost to Medicare of brand-name pharmaceutical drugs. These challenges—initiated in federal court by major pharmaceutical manufacturers—have largely been unsuccessful, rejected in both federal district and appeals courts in the Second and Third Circuits, with writs of certiorari uniformly denied by the U.S. Supreme Court. But all hope is not yet lost for pharmaceutical manufacturers’ opposition to the DPNP. A few challenges remain pending in the U.S. Courts of Appeals for the District of Columbia and Fifth Circuits, with the latter signaling potential receptiveness to the manufacturers’ positions at oral argument. To continue reading Amy Vegari and...
Publication
SEC Proposes Regulation E-Delivery: Default Electronic Delivery for Federal Securities Law Communications
On July 16, 2026, the U.S. Securities and Exchange Commission (the “SEC” or “Commission”) proposed Regulation E-Delivery[i], a new regulatory framework that would permit covered entities to deliver required information to investors and other recipients electronically as the default method, without first obtaining affirmative consent. In an accompanying statement, SEC Chairman Paul S. Atkins characterized the proposal as “an important step toward allowing the financial services industry to harness technology for the benefit of everyday American investors” and “another stride toward a regulatory framework suitable for the modern era.”[ii] Proposed Regulation E-Delivery would establish uniform conditions under which the federal securities laws’ information delivery requirements are satisfied by electronic delivery. The proposal would generally supersede the Commission’s 1995[iii] and 1996[iv] e-delivery...
Blog Post
Bankruptcy Court Decides Issue of First Impression Concerning Code Section 365(h)
When a debtor that is a landlord rejects a real property lease in bankruptcy, the tenant has a choice. Either the tenant can treat the lease as terminated or retain its rights under the lease. These rights include the use, possession, quiet enjoyment, subletting, and hypothecation of the property. In a recent case, the parties and the court grappled with this question: when does the tenant need to make that decision? When the lease is rejected, or by some other date? Interestingly, neither the court nor the parties found case law on this issue. It was one of first impression. In re All Star Props., LLC, No. 25-41314, 2026 Bankr. LEXIS 1461 (Bankr. N.D. Ga. June 15, 2026). The debtor owns...
Firm News
Firm Amicus Brief Plays Key Role in U.S. Supreme Court Dissent
Patterson Belknap submitted an amicus brief that played a significant role in Justice Sonia Sotomayor's June 29, 2026 dissent in Trump v. Slaughter. The brief was filed on behalf of legal historians Noah A. Rosenblum and Nathaniel Donahue, arguing that the concepts "quasi-legislative" and "quasi-judicial" as used in Humphrey's Executor had long histories in American law and provide workable definitions to guide the Court's review of congressional limitations.  In the dissent, Justice Sotomayor, joined by Justices Elena Kagan and Ketanji Brown-Jackson, cited the brief extensively. Justice Sotomayor relied on the brief to explain that the concepts were well-established well before the Humphrey's decision, and were used by many political figures and by courts developing a “quasi-judicial” category for officers whose duties resembled a judge’s. To read the amicus brief, please...
Blog Post
Fees Recoverable by Oversecured Creditors in Bankruptcy: The Application of Code Sections 506(b) and 502(b)
Bankruptcy Code section 506(b) entitles an oversecured creditor to post-petition interest and reasonable fees and other charges. Are a creditor’s pre-petition charges also subject to a court’s view of what is reasonable? Courts are split on this issue. A judge in New York recently explained why, in his view, reasonableness is not the right standard for the pre-petition portion of a claim. Pre-petition charges should be determined by applicable state law and not a judge’s analysis of what is reasonable. In re 1300 Desert Willow Road, LLC, No. 25-11375, 2026 WL 2088511 (Bankr. S.D.N.Y. Jul. 20, 2026). The debtor is a single-asset real estate company. The creditor had loaned the debtor $20 million secured by a mortgage on real property. The debtor...
Publication
The Growing Antitrust Risks Of AI Pricing For Health Insurers
As algorithmic pricing models continue to gain traction throughout industries, they increasingly face scrutiny from legislators, enforcers and private plaintiffs who fear their anticompetitive potential. The health insurance industry is no exception: Courts are seriously considering challenges to algorithmic models for health insurance pricing, and legislators are also stepping in. This article focuses on recent legislative and enforcement trends to regulate this developing technology, as well as two ongoing cases involving algorithmic pricing in the health insurance industry, In re: MultiPlan Health Insurance Provider Litigation in the U.S. District Court for the Northern District of Illinois and In re: Zelis Repricing Antitrust Litigation in the U.S. District Court for the District of Massachusetts. Both cases are now in discovery as the plaintiffs continue to pursue...
Firm News
Patterson Belknap Recognized by Chambers in its 2026 High Net Worth Guide
Patterson Belknap Webb & Tyler is pleased to announce that the firm has been recognized by Chambers High Net Worth 2026 in the following practice areas: Art and Cultural Property Law – USA-Nationwide Private Wealth Law – New York Chambers is a leading independent professional legal research company, delivering detailed rankings and insights into the world’s top lawyers and law firms. Its research methodology includes detailed interviews with clients and peers and analysis of capabilities, achievement, and sector presence. The firm also received individual recognitions by Chambers in both practice areas: Anne-Laure Alléhaut is ranked in the Art and Cultural Property Law practice area in the USA. Michael Arlein is ranked in the Private Wealth Law practice area in New York. Comments regarding the firm in the Chambers High Net Worth...
Blog Post
Supreme Court Reaffirms Disgorgement in Sripetch, But Jury Question Looms
In our January 2026 post, Supreme Court to Clarify the SEC’s Disgorgement Powers, we previewed the Supreme Court’s decision to take up Sripetch v. Securities & Exchange Commission,[1] a case in which defendants sought to pare back the SEC’s authority to seek disgorgement. The case resolves a circuit split that arose in the wake of Liu v. SEC.[2]  In Liu, the Court sought to clarify the SEC’s ability to impose the penalty of disgorgement, ruling that disgorgement was available as equitable relief, but to avoid transforming an equitable remedy into a punitive one, “the remedy [is restricted] to an individual wrongdoer’s net profits to be awarded for victims.” In response to Liu’s requirement that disgorgement be “awarded for victims,” the Second Circuit...
Blog Post
Regulation E-Delivery: SEC Proposes to Make Electronic Communication the Default
On July 16, 2026, the Securities and Exchange Commission announced a proposed rule to broaden many financial market participants’ use of electronic communications with investors and others who receive information pursuant to federal securities laws.[1]  Referred to as “Reg E-Delivery,” the new rule aims to help issuers and others who disseminate SEC-required information transition away from delivering paper documents, a communication method the Agency pointed out imposes “unnecessary costs and expenses” while “no longer reflect[ing] the preference of most investors.”[2] Commenting on the proposed rule, Chair Atkins stated: The world has changed dramatically since many of our rules were first adopted. But, all too often, our regulatory framework has remained static. … In an age of artificial intelligence and blockchain technology, a...
Firm News
Firm Tops The American Lawyer's 2026 Pro Bono Scorecard with Number 1 Ranking
Patterson Belknap has been recognized with a number 1 ranking in The American Lawyer's 2026 Pro Bono Scorecard. These rankings assess pro bono efforts among Am Law 200 firms and are based on the average number of pro bono hours per lawyer and the percentage of lawyers performing 20 or more pro bono hours in 2025. The Scorecard highlights the firm's “intense focus” on pro bono work, with an average of 185.7 hours per lawyer and 85.1% of firm lawyers doing more than 20 hours of pro bono. The article includes commentary from Pro Bono Chair, Michael F. Buchanan, on the firm’s commitment to both impact litigation and pro bono work that has an impact on people's lives, such as access to health care,...
Publication
Not Over Yet?: Drug Manufacturers Eye Potential Circuit Split on Federal Drug Pricing Program
The Inflation Reduction Act’s Drug Price Negotiation Program has been the subject of litigation since Congress passed it in 2022 in an effort to curb the cost to Medicare of brand-name pharmaceutical drugs. These challenges—initiated in federal court by major pharmaceutical manufacturers—have largely been unsuccessful, rejected in both federal district and appeals courts in the Second and Third Circuits, with writs of certiorari uniformly denied by the U.S. Supreme Court. But all hope is not yet lost for pharmaceutical manufacturers’ opposition to the DPNP. A few challenges remain pending in the U.S. Courts of Appeals for the District of Columbia and Fifth Circuits, with the latter signaling potential receptiveness to the manufacturers’ positions at oral argument. To continue reading Amy Vegari and...
Litigation, Disputes & Investigationsicon right
Exempt Organizations & Private Clientsicon right
Corporate & Transactionsicon right
  • Contact Us
  • Subscribe
  • Disclaimer
  • Privacy Policy

1133 Avenue of the Americas New York, New York 10036 | Tel: 212.336.2000
© 2026 Patterson Belknap Webb & Tyler LLP. All rights reserved. Attorney Advertising. Website Credits